171 related articles for article (PubMed ID: 9420657)
21. The use of cytokine inhibitors. A new therapeutic insight into heart failure.
Matsumori A
Int J Cardiol; 1997 Dec; 62 Suppl 1():S3-12. PubMed ID: 9464576
[TBL] [Abstract][Full Text] [Related]
22. Reassessment of digoxin and other low-dose positive inotropes in the treatment of chronic heart failure.
Tauke J; Han D; Gheorghiade M
Cardiovasc Drugs Ther; 1994 Oct; 8(5):761-8. PubMed ID: 7873474
[TBL] [Abstract][Full Text] [Related]
23. Vesnarinone for heart failure.
Swedberg K; Wedel H
N Engl J Med; 1994 Jan; 330(1):64; author reply 65. PubMed ID: 8259151
[No Abstract] [Full Text] [Related]
24. Inotropic agents in older patients with chronic heart failure--current perspectives.
Carbonin PU; Zuccalà G
Aging (Milano); 1996 Apr; 8(2):90-8. PubMed ID: 8737606
[TBL] [Abstract][Full Text] [Related]
25. Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure.
Sasayama S; Inoue M; Asanoi H; Kodama K; Hori M; Sakurai T; Kawai C
Heart Vessels; 1986; 2(1):23-8. PubMed ID: 3722083
[TBL] [Abstract][Full Text] [Related]
26. [Non-digitalis inotropic agents in the treatment of congestive heart insufficiency].
Correia JF
Rev Port Cardiol; 1989 Jun; 8(6):473-81. PubMed ID: 2698714
[TBL] [Abstract][Full Text] [Related]
27. Update on digoxin and other oral positive inotropic agents for chronic heart failure.
Reddy S; Benatar D; Gheorghiade M
Curr Opin Cardiol; 1997 May; 12(3):233-41. PubMed ID: 9243080
[TBL] [Abstract][Full Text] [Related]
28. [Inotropic agents].
Sasayama S
Nihon Rinsho; 2003 May; 61(5):807-14. PubMed ID: 12755007
[TBL] [Abstract][Full Text] [Related]
29. Potential mechanisms of improved left ventricular function with enoximone in severe congestive heart failure.
Chatterjee K; Kereiakes D; Viquerat C; Podolin R
Am J Cardiol; 1987 Aug; 60(5):37C-41C. PubMed ID: 2956866
[TBL] [Abstract][Full Text] [Related]
30. The role of novel inotropic agents in the treatment of heart failure.
LeJemtel TH; Keren G; Reis D; Sonnenblick EH
J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542
[TBL] [Abstract][Full Text] [Related]
31. Medical advances in the treatment of congestive heart failure.
Armstrong PW; Moe GW
Circulation; 1993 Dec; 88(6):2941-52. PubMed ID: 7902784
[TBL] [Abstract][Full Text] [Related]
32. Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure.
Kjeldsen K; Nørgaard A; Gheorghiade M
Cardiovasc Res; 2002 Sep; 55(4):710-3. PubMed ID: 12176120
[TBL] [Abstract][Full Text] [Related]
33. Sustained inotropic effects of a new cardiotonic agent. OPC-8212 in patients with chronic heart failure.
Asanoi H; Sasayama S; Kameyama T; Ishizaka S; Iuchi K
Clin Cardiol; 1989 Mar; 12(3):133-8. PubMed ID: 2647327
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
35. Inotropic agents in the treatment of heart failure: despair or hope?
Sasayama S
Cardiovasc Drugs Ther; 1997 Jan; 10(6):703-9. PubMed ID: 9110113
[TBL] [Abstract][Full Text] [Related]
36. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
37. Importance of assessing changes in ventricular response to atrial fibrillation during evaluation of new heart failure therapies: experience from trials of flosequinan.
Massie BM; Shah NB; Pitt B; Packer M
Am Heart J; 1996 Jul; 132(1 Pt 1):130-6. PubMed ID: 8701855
[TBL] [Abstract][Full Text] [Related]
38. A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment.
Inoue M; Hori M; Yasuda H; Takishima T; Sugimoto T; Sasayama S; Sakurai T; Nonogi H; Kodama K; Kusukawa R
Cardiovasc Drugs Ther; 1987 Aug; 1(2):169-75. PubMed ID: 3154320
[TBL] [Abstract][Full Text] [Related]
39. Dose-related hemodynamic and electrocardiographic effects of the calcium promoter BAY y 5959 in the presence or absence of congestive heart failure.
Rousseau MF; Massart PE; van Eyll C; Etienne J; Ahn S; Schaefer HG; Mueck W; Bornemann M; Pouleur H
J Am Coll Cardiol; 1997 Dec; 30(7):1751-7. PubMed ID: 9385903
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan: a new era for inodilator therapy for heart failure?
Cleland JG; McGowan J
Curr Opin Cardiol; 2002 May; 17(3):257-65. PubMed ID: 12015475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
